CA Stock MarketDetailed Quotes

HLS HLS Therapeutics Inc

Watchlist
  • 3.640
  • -0.010-0.27%
15min DelayMarket Closed Dec 13 16:00 ET
115.73MMarket Cap-3.90P/E (TTM)

HLS Therapeutics Inc Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-72.03%1.5M
-5.58%2.52M
-80.65%778K
-6.81%15.79M
6.05%3.73M
29.29%5.37M
-24.03%2.67M
-30.18%4.02M
3.12%16.94M
-11.49%3.52M
Net income from continuing operations
29.81%-4.84M
39.79%-5.68M
-5.42%-6.11M
-16.67%-27.53M
15.99%-5.4M
-56.49%-6.9M
-3.22%-9.44M
-60.18%-5.79M
-79.90%-23.6M
-53.51%-6.43M
Operating gains losses
--0
----
----
----
----
----
----
----
----
----
Depreciation and amortization
-32.89%5.51M
-30.00%5.86M
-28.85%5.92M
-7.16%31.94M
-18.93%7.05M
-7.10%8.21M
-1.45%8.37M
-0.81%8.32M
13.67%34.4M
8.04%8.69M
Asset impairment expenditure
--0
----
----
27.60%3.89M
--1.54M
--0
----
----
--3.05M
--0
Unrealized gains and losses of investment securities
-99.11%18K
-44.21%318K
-66.06%187K
223.95%2.89M
-210.97%-263K
611.34%2.03M
181.90%570K
137.38%551K
-18.27%-2.33M
129.74%237K
Remuneration paid in stock
2,789.47%511K
211.68%427K
565.45%256K
-118.41%-538K
-179.92%-601K
-115.20%-19K
-88.86%137K
-106.75%-55K
24.13%2.92M
42.16%752K
Deferred tax
91.31%-47K
4,642.35%3.86M
65.54%-61K
-604.35%-696K
212.63%107K
-176.02%-541K
-525.00%-85K
-143.28%-177K
-87.85%138K
-115.40%-95K
Other non cashItems
77.39%353K
45.79%277K
47.64%282K
-1.60%797K
9.60%217K
-0.50%199K
-7.32%190K
-7.73%191K
3.45%810K
-3.88%198K
Change In working capital
-99.92%2K
46.61%843K
-69.38%301K
225.60%5.04M
554.82%1.09M
47,940.00%2.39M
61.52%575K
-4.56%983K
151.21%1.55M
138.25%166K
-Change in receivables
-207.54%-1.24M
120.34%346K
-21.33%837K
377.44%738K
128.96%221K
1,168.13%1.15M
-183.50%-1.7M
5.77%1.06M
-125.48%-266K
-238.48%-763K
-Change in inventory
19.41%1.22M
70.83%1.19M
56.35%-770K
-6.27%-661K
-149.52%-613K
291.37%1.02M
138.77%696K
-476.92%-1.76M
-135.18%-622K
42.30%1.24M
-Change in payables and accrued expense
-46.13%842K
-286.16%-1.12M
-134.86%-495K
-27.72%2.27M
34.01%-423K
901.92%1.56M
-107.99%-289K
14,100.00%1.42M
176.75%3.14M
65.28%-641K
-Change in other current assets
279.35%588K
-126.59%-750K
810.00%273K
217.75%199K
131.54%345K
-46.37%155K
58.10%-331K
-83.61%30K
75.68%-169K
--149K
-Change in other working capital
6.33%-1.41M
-46.64%1.17M
95.71%456K
562.83%2.49M
750.82%1.56M
-18,650.00%-1.5M
2,994.74%2.2M
136.58%233K
48.47%-538K
-22.46%183K
Cash from discontinued investing activities
Operating cash flow
-72.03%1.5M
-5.58%2.52M
-80.65%778K
-6.81%15.79M
6.05%3.73M
29.29%5.37M
-24.03%2.67M
-30.18%4.02M
3.12%16.94M
-11.49%3.52M
Investing cash flow
Cash flow from continuing investing activities
-3,650.00%-1.5M
9,914.81%13.25M
-2K
98.14%-189K
30.00%-14K
99.60%-40K
-66.67%-135K
0
-125.01%-10.15M
95.26%-20K
Net PPE purchase and sale
--0
--0
---2K
8.89%-41K
-55.56%-14K
--0
-80.00%-27K
--0
4.26%-45K
59.09%-9K
Net intangibles purchas and sale
--0
----
----
98.54%-148K
--0
99.60%-40K
----
----
-126.37%-10.1M
97.25%-11K
Cash from discontinued investing activities
Investing cash flow
-3,650.00%-1.5M
9,914.81%13.25M
---2K
98.14%-189K
30.00%-14K
99.60%-40K
-66.67%-135K
--0
-125.01%-10.15M
95.26%-20K
Financing cash flow
Cash flow from continuing financing activities
-251.81%-15.1M
12.48%-2.58M
13.66%-3.03M
-113.52%-14.64M
5.08%-3.89M
-167.77%-4.29M
38.54%-2.95M
18.22%-3.51M
39.85%-6.86M
1.82%-4.09M
Net issuance payments of debt
-548.45%-15.1M
-3.75%-1.61M
2.80%-2.22M
-2,045.80%-9.46M
-29.60%-3.31M
-127.55%-2.33M
51.35%-1.55M
27.76%-2.28M
96.04%-441K
19.30%-2.55M
Net common stock issuance
--0
-71.35%-317K
-53.80%-283K
-55.51%-1.55M
-65.71%-580K
-123.33%-603K
48.18%-185K
-776.19%-184K
-2,023.40%-998K
---350K
Cash dividends paid
--0
--0
--0
51.67%-2.4M
--0
--0
4.03%-1.22M
7.80%-1.18M
3.12%-4.96M
5.99%-1.19M
Proceeds from stock option exercised by employees
--0
--0
--0
-27.17%134K
--0
--0
--0
-18.79%134K
-96.25%184K
--0
Net other financing activities
--0
---658K
---533K
-112.83%-1.36M
--0
----
----
----
---639K
--0
Cash from discontinued financing activities
Financing cash flow
-251.81%-15.1M
12.48%-2.58M
13.66%-3.03M
-113.52%-14.64M
5.08%-3.89M
-167.77%-4.29M
38.54%-2.95M
18.22%-3.51M
39.85%-6.86M
1.82%-4.09M
Net cash flow
Beginning cash position
55.34%32.52M
-8.35%19.44M
5.93%21.95M
-2.15%20.72M
2.49%21.81M
-1.08%20.93M
-6.40%21.21M
-2.15%20.72M
2.75%21.18M
-2.10%21.28M
Current changes in cash
-1,557.05%-15.1M
3,278.07%13.19M
-546.25%-2.26M
1,650.00%961K
72.01%-166K
119.96%1.04M
69.62%-415K
-64.52%506K
-111.90%-62K
3.42%-593K
Effect of exchange rate changes
175.00%120K
-187.97%-117K
-1,573.33%-251K
168.02%268K
737.84%310K
54.55%-160K
196.38%133K
-125.42%-15K
-956.52%-394K
-35.09%37K
End cash Position
-19.57%17.54M
55.34%32.52M
-8.35%19.44M
5.93%21.95M
5.93%21.95M
2.49%21.81M
-1.08%20.93M
-6.40%21.21M
-2.15%20.72M
-2.15%20.72M
Free cash from
-71.82%1.5M
-0.55%2.52M
-80.70%776K
129.61%15.6M
6.26%3.72M
190.89%5.33M
-26.17%2.53M
-29.76%4.02M
-43.00%6.79M
-1.55%3.5M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -72.03%1.5M-5.58%2.52M-80.65%778K-6.81%15.79M6.05%3.73M29.29%5.37M-24.03%2.67M-30.18%4.02M3.12%16.94M-11.49%3.52M
Net income from continuing operations 29.81%-4.84M39.79%-5.68M-5.42%-6.11M-16.67%-27.53M15.99%-5.4M-56.49%-6.9M-3.22%-9.44M-60.18%-5.79M-79.90%-23.6M-53.51%-6.43M
Operating gains losses --0------------------------------------
Depreciation and amortization -32.89%5.51M-30.00%5.86M-28.85%5.92M-7.16%31.94M-18.93%7.05M-7.10%8.21M-1.45%8.37M-0.81%8.32M13.67%34.4M8.04%8.69M
Asset impairment expenditure --0--------27.60%3.89M--1.54M--0----------3.05M--0
Unrealized gains and losses of investment securities -99.11%18K-44.21%318K-66.06%187K223.95%2.89M-210.97%-263K611.34%2.03M181.90%570K137.38%551K-18.27%-2.33M129.74%237K
Remuneration paid in stock 2,789.47%511K211.68%427K565.45%256K-118.41%-538K-179.92%-601K-115.20%-19K-88.86%137K-106.75%-55K24.13%2.92M42.16%752K
Deferred tax 91.31%-47K4,642.35%3.86M65.54%-61K-604.35%-696K212.63%107K-176.02%-541K-525.00%-85K-143.28%-177K-87.85%138K-115.40%-95K
Other non cashItems 77.39%353K45.79%277K47.64%282K-1.60%797K9.60%217K-0.50%199K-7.32%190K-7.73%191K3.45%810K-3.88%198K
Change In working capital -99.92%2K46.61%843K-69.38%301K225.60%5.04M554.82%1.09M47,940.00%2.39M61.52%575K-4.56%983K151.21%1.55M138.25%166K
-Change in receivables -207.54%-1.24M120.34%346K-21.33%837K377.44%738K128.96%221K1,168.13%1.15M-183.50%-1.7M5.77%1.06M-125.48%-266K-238.48%-763K
-Change in inventory 19.41%1.22M70.83%1.19M56.35%-770K-6.27%-661K-149.52%-613K291.37%1.02M138.77%696K-476.92%-1.76M-135.18%-622K42.30%1.24M
-Change in payables and accrued expense -46.13%842K-286.16%-1.12M-134.86%-495K-27.72%2.27M34.01%-423K901.92%1.56M-107.99%-289K14,100.00%1.42M176.75%3.14M65.28%-641K
-Change in other current assets 279.35%588K-126.59%-750K810.00%273K217.75%199K131.54%345K-46.37%155K58.10%-331K-83.61%30K75.68%-169K--149K
-Change in other working capital 6.33%-1.41M-46.64%1.17M95.71%456K562.83%2.49M750.82%1.56M-18,650.00%-1.5M2,994.74%2.2M136.58%233K48.47%-538K-22.46%183K
Cash from discontinued investing activities
Operating cash flow -72.03%1.5M-5.58%2.52M-80.65%778K-6.81%15.79M6.05%3.73M29.29%5.37M-24.03%2.67M-30.18%4.02M3.12%16.94M-11.49%3.52M
Investing cash flow
Cash flow from continuing investing activities -3,650.00%-1.5M9,914.81%13.25M-2K98.14%-189K30.00%-14K99.60%-40K-66.67%-135K0-125.01%-10.15M95.26%-20K
Net PPE purchase and sale --0--0---2K8.89%-41K-55.56%-14K--0-80.00%-27K--04.26%-45K59.09%-9K
Net intangibles purchas and sale --0--------98.54%-148K--099.60%-40K---------126.37%-10.1M97.25%-11K
Cash from discontinued investing activities
Investing cash flow -3,650.00%-1.5M9,914.81%13.25M---2K98.14%-189K30.00%-14K99.60%-40K-66.67%-135K--0-125.01%-10.15M95.26%-20K
Financing cash flow
Cash flow from continuing financing activities -251.81%-15.1M12.48%-2.58M13.66%-3.03M-113.52%-14.64M5.08%-3.89M-167.77%-4.29M38.54%-2.95M18.22%-3.51M39.85%-6.86M1.82%-4.09M
Net issuance payments of debt -548.45%-15.1M-3.75%-1.61M2.80%-2.22M-2,045.80%-9.46M-29.60%-3.31M-127.55%-2.33M51.35%-1.55M27.76%-2.28M96.04%-441K19.30%-2.55M
Net common stock issuance --0-71.35%-317K-53.80%-283K-55.51%-1.55M-65.71%-580K-123.33%-603K48.18%-185K-776.19%-184K-2,023.40%-998K---350K
Cash dividends paid --0--0--051.67%-2.4M--0--04.03%-1.22M7.80%-1.18M3.12%-4.96M5.99%-1.19M
Proceeds from stock option exercised by employees --0--0--0-27.17%134K--0--0--0-18.79%134K-96.25%184K--0
Net other financing activities --0---658K---533K-112.83%-1.36M--0---------------639K--0
Cash from discontinued financing activities
Financing cash flow -251.81%-15.1M12.48%-2.58M13.66%-3.03M-113.52%-14.64M5.08%-3.89M-167.77%-4.29M38.54%-2.95M18.22%-3.51M39.85%-6.86M1.82%-4.09M
Net cash flow
Beginning cash position 55.34%32.52M-8.35%19.44M5.93%21.95M-2.15%20.72M2.49%21.81M-1.08%20.93M-6.40%21.21M-2.15%20.72M2.75%21.18M-2.10%21.28M
Current changes in cash -1,557.05%-15.1M3,278.07%13.19M-546.25%-2.26M1,650.00%961K72.01%-166K119.96%1.04M69.62%-415K-64.52%506K-111.90%-62K3.42%-593K
Effect of exchange rate changes 175.00%120K-187.97%-117K-1,573.33%-251K168.02%268K737.84%310K54.55%-160K196.38%133K-125.42%-15K-956.52%-394K-35.09%37K
End cash Position -19.57%17.54M55.34%32.52M-8.35%19.44M5.93%21.95M5.93%21.95M2.49%21.81M-1.08%20.93M-6.40%21.21M-2.15%20.72M-2.15%20.72M
Free cash from -71.82%1.5M-0.55%2.52M-80.70%776K129.61%15.6M6.26%3.72M190.89%5.33M-26.17%2.53M-29.76%4.02M-43.00%6.79M-1.55%3.5M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Price
% Chg

No Data